DUBLIN--(BUSINESS WIRE)--The "Western Blotting: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for Western blotting was valued at $1.4 billion in 2022 ...

Bio-Rad Laboratories, Inc. (BIO) has experienced a rise in revenue growth in recent years thanks to strong sales of its Western Blotting, Digital PCR, and Process Media life science products. Several ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today released the first set in a new product line of PrecisonAb™ Antibodies, rigorously validated for use in western blotting. These antibodies offer ...

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of its isotype-specific secondary antibodies.

Longleaf Partners, managed by Southeastern Asset Management, released its “Partners Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -6.31% in ...